Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Lewis

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Plos Pathogens|September 7, 2013
Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infectionSunita Gulati, Bo Zheng, George W Reed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistanceGuillermo Madico, Jo Anne Welsch, Lisa A Lewis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2020
Therapeutic CMP-Nonulosonates against Multidrug-Resistant <i>Neisseria gonorrhoeae</i>Sunita Gulati, Ian C Schoenhofen, Theresa Lindhout-Djukic, et al.
The Journal of Infectious Diseases|July 22, 2020
Efficacy of Antigonococcal CMP-Nonulosonate Therapeutics Require CathelicidinsSunita Gulati, Ian C Schoenhofen, Theresa Lindhout-Djukic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2018
Human Factor H Domains 6 and 7 Fused to IgG1 Fc Are Immunotherapeutic against <i>Neisseria gonorrhoeae</i>Jutamas Shaughnessy, Lisa A Lewis, Bo Zheng, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeaeRichard A Alm, Sushmita D Lahiri, Amy Kutschke, et al.
Frontiers in Immunology|September 16, 2022
An optimized Factor H-Fc fusion protein against multidrug-resistant <i>Neisseria gonorrhoeae</i>Jutamas Shaughnessy, Aleyo Chabeda, Y Tran, et al.
NPJ Vaccines|June 8, 2026
Pre-clinical efficacy of a candidate outer membrane vesicle gonococcal vaccine in comparison with 4CMenBPaula Freixeiro, Lisa A Lewis, Leonor Sánchez-Busó, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2016
A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeaeJutamas Shaughnessy, Sunita Gulati, Sarika Agarwal, et al.
The Journal of Infectious Diseases|December 31, 2021
Efficacy of an Experimental Gonococcal Lipooligosaccharide Mimitope Vaccine Requires Terminal ComplementLisa A Lewis, Sunita Gulati, Wioleta M Zelek, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Plos Pathogens|September 7, 2013
Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infectionSunita Gulati, Bo Zheng, George W Reed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistanceGuillermo Madico, Jo Anne Welsch, Lisa A Lewis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2020
Therapeutic CMP-Nonulosonates against Multidrug-Resistant <i>Neisseria gonorrhoeae</i>Sunita Gulati, Ian C Schoenhofen, Theresa Lindhout-Djukic, et al.
The Journal of Infectious Diseases|July 22, 2020
Efficacy of Antigonococcal CMP-Nonulosonate Therapeutics Require CathelicidinsSunita Gulati, Ian C Schoenhofen, Theresa Lindhout-Djukic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2018
Human Factor H Domains 6 and 7 Fused to IgG1 Fc Are Immunotherapeutic against <i>Neisseria gonorrhoeae</i>Jutamas Shaughnessy, Lisa A Lewis, Bo Zheng, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeaeRichard A Alm, Sushmita D Lahiri, Amy Kutschke, et al.
Frontiers in Immunology|September 16, 2022
An optimized Factor H-Fc fusion protein against multidrug-resistant <i>Neisseria gonorrhoeae</i>Jutamas Shaughnessy, Aleyo Chabeda, Y Tran, et al.
NPJ Vaccines|June 8, 2026
Pre-clinical efficacy of a candidate outer membrane vesicle gonococcal vaccine in comparison with 4CMenBPaula Freixeiro, Lisa A Lewis, Leonor Sánchez-Busó, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2016
A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeaeJutamas Shaughnessy, Sunita Gulati, Sarika Agarwal, et al.
The Journal of Infectious Diseases|December 31, 2021
Efficacy of an Experimental Gonococcal Lipooligosaccharide Mimitope Vaccine Requires Terminal ComplementLisa A Lewis, Sunita Gulati, Wioleta M Zelek, et al.
Pageof 5